Filip Janku

Insider Reports History

Entity
Individual
Location
Monte Rosa Therapeutics, Inc., 40 Guest Street, Boston, MA
Signature
/s/ Markus Warmuth, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Filip Janku:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Monte Rosa Therapeutics, Inc. Chief Medical Officer Common Stock 5.25K $99.8K $19.00 Jan 2, 2024 Direct
Monte Rosa Therapeutics, Inc. Chief Medical Officer Stock Option (Right to Buy) 30K Sep 13, 2024 Direct

Insider Reports Filed by Filip Janku

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GLUE Monte Rosa Therapeutics, Inc. Sep 13, 2024 1 $0 4 Sep 13, 2024 Chief Medical Officer
GLUE Monte Rosa Therapeutics, Inc. Jan 2, 2024 1 $0 4 Jan 4, 2024 Chief Medical Officer
GLUE Monte Rosa Therapeutics, Inc. Jan 3, 2023 1 $0 4 Jan 4, 2023 Chief Medical Officer
GLUE Monte Rosa Therapeutics, Inc. Dec 15, 2022 1 $0 4 Dec 19, 2022 Chief Medical Officer
GLUE Monte Rosa Therapeutics, Inc. Oct 31, 2022 1 $0 4 Nov 1, 2022 Chief Medical Officer
GLUE Monte Rosa Therapeutics, Inc. Mar 1, 2022 1 $0 4 Mar 2, 2022 Chief Medical Officer
GLUE Monte Rosa Therapeutics, Inc. Jun 23, 2021 1 $0 4 Jun 25, 2021 Chief Medical Officer
GLUE Monte Rosa Therapeutics, Inc. Jun 23, 2021 0 $0 3 Jun 23, 2021 Chief Medical Officer